drugset / Trial / NCT03284034

Cryolipolysis Versus ATX-101 (Deoxycholic Acid) for Upper Back Fat

NCT03284034

Terminated 8 enrolled Northwestern University
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective randomized controlled study comparing the efficacy of cryolipolysis versus ATX-101 (deoxycholic acid) for the treatment of upper back fat. Participants currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. The treatment sites are the right and left upper back fat areas. The right and left sides of the upper back fat will be randomly assigned (1:1) to receive cryolipolysis, while the contralateral side will receive ATX-101. This study was a pilot study designed to determine feasibility of this procedure.

Timeline

Start
2017-11-27
Primary completion
2020-06-08
Completion
2020-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject ATX-101 Peptide

Indications

No indication recorded.